HIV Infections

Infectious Disease·MeSH: HIV Infections

Prevalence

380.0 / 100K

Incidence

12.0 / 100K/yr

21 drugs in development·9 companies·50 clinical trials

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
Poly ICLC	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 1(16)

Drug	Company
3M-05-AF	Valneva SE (VALN)
3M-052-AF	Valneva SE (VALN)
3M-052-AF	DYNAVAX TECHNOLOGIES CORP (DVAX)
9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use	Design Therapeutics, Inc. (DSGN)
Alum	DYNAVAX TECHNOLOGIES CORP (DVAX)
Aluminum hydroxide suspension	Valneva SE (VALN)
BG505 SOSIP.664 gp140	DYNAVAX TECHNOLOGIES CORP (DVAX)
CD40.HIVRI.Env	Crinetics Pharmaceuticals, Inc. (CRNX)
CH505 TF chTrimer	Valneva SE (VALN)
GLA-LSQ	DYNAVAX TECHNOLOGIES CORP (DVAX)
Hiltonol Poly-ICLC-adjuvant	Crinetics Pharmaceuticals, Inc. (CRNX)
jl18008	Day One Biopharmaceuticals, Inc. (DAWN)
mRNA-1645-CoreG28v2	Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-eODGT8	Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-N332GT5	Cidara Therapeutics, Inc. (CDTX)
Trimer 4571	DYNAVAX TECHNOLOGIES CORP (DVAX)

Unknown(1)

Drug	Company
label chg for erika model 9608 arterial blood line	National Research Corporation Common Stock (Delaware) (NRC)

N/A(1)

Drug	Company
PrEP for participants without HIV	BIOMERICA INC (BMRA)

Phase 4(2)

Drug	Company
Cabotegravir Injection	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Cabotegravir Pill	COLLEGIUM PHARMACEUTICAL, INC (COLL)

BioSniper tracks 21 drugs in development for HIV Infections across 9 companies.

There are 50 clinical trials targeting HIV Infections tracked by BioSniper.

The estimated prevalence of HIV Infections is approximately 380.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.